These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9778761)

  • 21. Lipid peroxidation and glutathione levels after cortical injection of ferric chloride in rats: effect of trimetazidine and deferoxamine.
    Suzer T; Coskun E; Demir S; Tahta K
    Res Exp Med (Berl); 2000 Feb; 199(4):223-9. PubMed ID: 10743680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Actions of tacrine and galanthamine on histamine-N-methyltransferase.
    Taraschenko OD; Barnes WG; Herrick-Davis K; Yokoyama Y; Boyd DL; Hough LB
    Methods Find Exp Clin Pharmacol; 2005 Apr; 27(3):161-5. PubMed ID: 15834447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detrimental effects of N-acetylcysteine plus desferoxamine combination in an experimental nephrotic syndrome model.
    Bulucu F; Oktenli C; Kenar L; Koc B; Ocal R; Karadurmus N; Inal V; Yamanel L; Sanisoglu YS; Aydin A
    Int J Toxicol; 2007; 26(6):525-32. PubMed ID: 18066968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An investigation of the effect of tacrine and physostigmine on spatial working memory deficits in the olfactory bulbectomised rat.
    Hallam KT; Horgan JE; McGrath C; Norman TR
    Behav Brain Res; 2004 Aug; 153(2):481-6. PubMed ID: 15265646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
    Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
    Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New performance of biosensor technology for Alzheimer's disease drugs: in vitro comparison of tacrine and 7-methoxytacrine.
    Pohanka M; Kuca K; Kassa J
    Neuro Endocrinol Lett; 2008 Oct; 29(5):755-8. PubMed ID: 18987590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Motor dysfunction produced by tacrine administration in rats.
    Carriero DL; Outslay G; Mayorga AJ; Aberman J; Gianutsos G; Salamone JD
    Pharmacol Biochem Behav; 1997 Dec; 58(4):851-8. PubMed ID: 9408186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative studies on the efficacy of chelating agents in experimental iron storage disease in the rat].
    Bohne F; Harmuth-Hoene AE; Weber KM
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(4):409-19. PubMed ID: 4232727
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative aluminum mobilizing actions of deferoxamine and four 3-hydroxypyrid-4-ones in aluminum-loaded rats.
    Gómez M; Esparza JL; Domingo JL; Singh PK; Jones MM
    Toxicology; 1998 Sep; 130(2-3):175-81. PubMed ID: 9865484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An experimental study of ototoxicity induced by deferoxamine mesilate].
    Yamanobe S; Kanno H
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Aug; 101(8):979-87. PubMed ID: 9778943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of conjugated deferoxamine in porcine skin flaps.
    Hom DB; Goding GS; Price JA; Pernell KJ; Maisel RH
    Head Neck; 2000 Sep; 22(6):579-84. PubMed ID: 10941159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo comparative studies on chelation of aluminum by some polyaminocarboxylic acids.
    Graff L; Muller G; Burnel D
    Res Commun Mol Pathol Pharmacol; 1995 Jun; 88(3):271-92. PubMed ID: 8564384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel animal model to evaluate the ability of a drug delivery system to promote the passage through the BBB.
    Iannone M; Cosco D; Cilurzo F; Celia C; Paolino D; Mollace V; Rotiroti D; Fresta M
    Neurosci Lett; 2010 Jan; 469(1):93-6. PubMed ID: 19944736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of desferrioxamine (DFO) for removal of thallium ions in rat.
    Fatemi SJ; Amiri A; Bazargan MH; Tubafard S; Fatemi SN
    Int J Artif Organs; 2007 Oct; 30(10):902-5. PubMed ID: 17992651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the chelator desferrioxamine on aluminum elimination in rabbits.
    Melograna JM; Yokel RA
    Res Commun Chem Pathol Pharmacol; 1983 Jun; 40(3):497-509. PubMed ID: 6622822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term oral administration of memory-enhancing doses of tacrine in mice: a study of potential toxicity and side effects.
    Fitten LJ; Flood JF; Baxter CF; Tachiki KH; Perryman K
    J Gerontol; 1987 Nov; 42(6):681-5. PubMed ID: 3680887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of exposure to parenteral and oral aluminum with and without citrate using a desferrioxamine test in rats.
    Greger JL; Powers CF
    Toxicology; 1992 Nov; 76(2):119-32. PubMed ID: 1462356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of chelating agents in the treatment of aluminum overload.
    Domingo JL
    J Toxicol Clin Toxicol; 1989; 27(6):355-67. PubMed ID: 2697761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and genetic association of interleukin-6 in tacrine-induced hepatotoxicity.
    Carr DF; Alfirevic A; Tugwood JD; Barratt BJ; Sherwood J; Smith J; Pirmohamed M; Park BK
    Pharmacogenet Genomics; 2007 Nov; 17(11):961-72. PubMed ID: 18075466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.